In Vitro and In Vivo Activities of LB 10827, a New Oral Cephalosporin, against Respiratory Pathogens

The in vitro antibacterial activities of LB 10827, a new oral cephalosporin, against common respiratory tract pathogens were compared with those of six β-lactams (cefdinir, cefuroxime, cefprozil, penicillin G, amoxicillin-clavulanate, and ampicillin), two quinolones (trovafloxacin and ciprofloxacin)...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Paek, Kyong-Sook, Kim, Mu-Yong, Lee, Chang-Seok, Youn, Hasik
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90191/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11083626/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.12.3272-3277.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!